Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
11.83
-0.51 (-4.13%)
At close: Mar 20, 2026, 4:00 PM EDT
11.70
-0.13 (-1.10%)
After-hours: Mar 20, 2026, 7:26 PM EDT

Amneal Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,7223,9642,4541,861301716
Market Cap Growth
37.08%61.50%31.89%517.27%-57.88%6.05%
Enterprise Value
6,1256,3974,7534,5052,9773,313
Last Close Price
11.8312.607.926.071.994.79
PE Ratio
53.7757.27-20.84-12.65-2.3168.43
Forward PE
11.9415.0411.6911.922.715.65
PEG Ratio
-0.510.510.510.180.66
PS Ratio
1.231.310.880.780.140.34
PB Ratio
624.19-27.89-11.2246.760.620.98
P/TBV Ratio
-27.04-28.80-11.1826.87--
P/FCF Ratio
15.4316.4410.456.2318.493.75
P/OCF Ratio
10.9511.668.325.384.632.96
EV/Sales Ratio
2.032.121.701.881.351.58
EV/EBITDA Ratio
9.5110.369.7910.3920.508.58
EV/EBIT Ratio
14.5616.2319.0722.04-31.3621.69
EV/FCF Ratio
25.4026.5320.2515.08182.6017.35
Debt / Equity Ratio
-40.81-40.81-15.2733.237.133.77
Debt / EBITDA Ratio
4.354.355.346.3419.597.45
Debt / FCF Ratio
11.1511.1511.059.21174.5015.07
Net Debt / Equity Ratio
-16.73-16.73-11.3166.635.833.60
Net Debt / EBITDA Ratio
3.853.855.106.1119.356.78
Net Debt / FCF Ratio
9.869.8610.548.87172.3313.72
Asset Turnover
0.840.840.800.660.570.53
Inventory Turnover
3.133.132.972.832.802.70
Quick Ratio
1.371.370.790.841.031.36
Current Ratio
2.172.171.411.631.882.24
Return on Equity (ROE)
-116.61%-116.61%203.14%-20.55%-44.55%2.78%
Return on Assets (ROA)
10.09%10.09%9.60%6.80%-2.52%2.47%
Return on Invested Capital (ROIC)
13.79%13.79%12.21%8.15%-3.05%3.17%
Return on Capital Employed (ROCE)
15.25%15.25%9.98%7.21%-3.01%4.63%
Earnings Yield
1.94%1.75%-4.80%-7.91%-43.22%1.46%
FCF Yield
6.48%6.08%9.57%16.06%5.41%26.67%
Buyback Yield / Dilution
0.51%0.51%0.28%0.10%0.96%0.25%
Updated Feb 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q